WRB grew its revenue from $7.2 billion in FY 2015 to $13.6 billion in FY 2024, a compound annual growth rate of 7.3%. Read ...

Of the 855 US-listed stocks covered by Morningstar analysts: 34% are undervalued, 39% are fairly valued, and 27% are ...

Of the 855 US-listed stocks covered by Morningstar analysts: 34% are undervalued, 39% are fairly valued, and 27% are ...

Mark will cover traditional passive ETFs that track broad indexes and will focus on how to pick the right ETF for you and ...

This moated ASX company's shares are in a prolonged slump. I quizzed our analyst Angus Hewitt on its management, the ...

Portfolio analytics that incorporate relevant benchmarks is important, perhaps more so in TAA than elsewhere. Click to read.

We recently compiled a list of the 12 Best Basic Materials Stocks to Buy According to Analysts. In this article, we are going ...

The launch by Chinese company DeepSeek of its R1 reasoning model last month caused chaos in U.S. markets. At the same time it ...

WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced it has been recognized as a 2025 Industry and Regional ...

Morningstar analyst Michael Makdad has also increased his target price to $47 from $46, implying a P/B multiple of 2 times.

Morningstar , Inc. (NASDAQ:MORN), a $13.9 billion market cap financial services company trading at a P/E ratio of 42.5, saw its Executive Chairman Joseph Mansueto recently sell shares of the company's ...

We recently compiled a list of the 12 Best Basic Materials Stocks to Buy According to Analysts. In this article, we are going ...